// App-Quantinova.ai

2276 : Etanercept (Enbrel®) Treatment Retention in the Sub-Population of Pediatric Patients from a Retrospective Cohort Study Using Canadian Claims-Level Data

Researchers

Presenter

  • Majed M M Khraishi

Principal Investigators

  • Brad Millson

  • John Woolcott

  • Heather Jones

  • Lisa Marshall

Medical Centers

  • Faculty of Medicine, Memorial University of Newfoundland, St. Johns, NF, Canada

  • Health Access & Outcomes, QuintilesIMS, Kanata, Canada

  • Inflammation & Immunology Global Outcomes & Evidence,, Pfizer, Inflammation & Immunology Global Outcomes & Evidence, Collegeville, PA

  • Inflammation & Immunology Global Medical Affairs, Pfizer, Collegeville, PA

Locations

  • Canada

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved